Literature DB >> 25925361

Molecular MRI differentiation between primary central nervous system lymphomas and high-grade gliomas using endogenous protein-based amide proton transfer MR imaging at 3 Tesla.

Shanshan Jiang1,2, Hao Yu1, Xianlong Wang1, Shilong Lu1, Yufa Li3, Lyujin Feng1, Yi Zhang2, Hye-Young Heo2, Dong-Hoon Lee2, Jinyuan Zhou4, Zhibo Wen5.   

Abstract

OBJECTIVES: To show the ability of using the amide proton transfer-weighted (APTW) MRI signals as imaging biomarkers to differentiate primary central nervous system lymphomas (PCNSLs) from high-grade gliomas (HGGs).
METHODS: Eleven patients with lymphomas and 21 patients with HGGs were examined. Magnetization-transfer (MT) spectra over an offset range of ± 6 ppm and the conventional MT ratio (MTR) at 15.6 ppm were acquired. The APTW signals, total chemical-exchange-saturation-transfer signal (integral between 0 and 5 ppm, CEST total), and MTR signal were obtained and compared between PCNSLs and HGGs. The diagnostic performance was assessed with the receiver operating characteristic (ROC) curve analysis.
RESULTS: The PCNSLs usually showed more homogeneous APTW hyperintensity (spatially compared to normal brain tissue) than the HGGs. The APTW max, APTW max-min and CEST total signal intensities were significantly lower (P < 0.05, 0.001 and 0.05, respectively), while the APTW min and MTR were significantly higher (both P < 0.01) in PCNSL lesions than in HGG lesions. The APTW values in peritumoral oedema were significantly lower for PCNSLs than for HGGs (P < 0.01). APTW max-min had the highest area under the ROC curve (0.963) and accuracy (94.1 %) in differentiating PCNSLs from HGGs.
CONCLUSIONS: The protein-based APTW signal would be a valuable MRI biomarker by which to identify PCNSLs and HGGs presurgically. KEY POINTS: PCNSLs overall showed more homogeneous APTW hyperintensity than HGGs. Maximum APTW signals were lower in PCNSL lesions than in HGG lesions. MTR signals were higher in PCNSLs than in HGGs. APTW heterogeneity had the highest accuracy in differentiating PCNSLs from HGGs.

Entities:  

Keywords:  APT imaging; Glioma; Lymphoma; Magnetization transfer; PCNSL

Mesh:

Substances:

Year:  2015        PMID: 25925361      PMCID: PMC4627862          DOI: 10.1007/s00330-015-3805-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  44 in total

1.  Magnetization transfer in MRI: a review.

Authors:  R M Henkelman; G J Stanisz; S J Graham
Journal:  NMR Biomed       Date:  2001-04       Impact factor: 4.044

2.  Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?

Authors:  B W Corn; S M Marcus; A Topham; W Hauck; W J Curran
Journal:  Cancer       Date:  1997-06-15       Impact factor: 6.860

Review 3.  Imaging of primary central nervous system lymphoma.

Authors:  John L Go; Sandy C Lee; Paul E Kim
Journal:  Neurosurg Focus       Date:  2006-11-15       Impact factor: 4.047

4.  Saturation power dependence of amide proton transfer image contrasts in human brain tumors and strokes at 3 T.

Authors:  Xuna Zhao; Zhibo Wen; Fanheng Huang; Shilong Lu; Xianlong Wang; Shuguang Hu; Donglin Zu; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2011-03-10       Impact factor: 4.668

5.  Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI.

Authors:  Anna Tietze; Jakob Blicher; Irene Klaerke Mikkelsen; Leif Østergaard; Megan K Strother; Seth A Smith; Manus J Donahue
Journal:  NMR Biomed       Date:  2013-11-28       Impact factor: 4.044

6.  Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response.

Authors:  Adrienne N Dula; Lori R Arlinghaus; Richard D Dortch; Blake E Dewey; Jennifer G Whisenant; Gregory D Ayers; Thomas E Yankeelov; Seth A Smith
Journal:  Magn Reson Med       Date:  2012-08-20       Impact factor: 4.668

Review 7.  Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment.

Authors:  James Rubenstein; Andrés J M Ferreri; Stefania Pittaluga
Journal:  Leuk Lymphoma       Date:  2008

8.  Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.

Authors:  Koji Yamashita; Takashi Yoshiura; Akio Hiwatashi; Osamu Togao; Koji Yoshimoto; Satoshi O Suzuki; Koichiro Abe; Kazufumi Kikuchi; Yasuhiro Maruoka; Masahiro Mizoguchi; Toru Iwaki; Hiroshi Honda
Journal:  Neuroradiology       Date:  2012-09-09       Impact factor: 2.804

9.  Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction.

Authors:  C H Toh; K-C Wei; C-N Chang; S-H Ng; H-F Wong
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

10.  Imaging in primary central nervous system lymphoma.

Authors:  V Lolli; D Tampieri; D Melançon; M Delpilar Cortes
Journal:  Neuroradiol J       Date:  2010-12-23
View more
  46 in total

1.  Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.

Authors:  Ayan Debnath; Rakesh Kumar Gupta; Anup Singh
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.

Authors:  Shanshan Jiang; Tianyu Zou; Charles G Eberhart; Maria A V Villalobos; Hye-Young Heo; Yi Zhang; Yu Wang; Xianlong Wang; Hao Yu; Yongxing Du; Peter C M van Zijl; Zhibo Wen; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2017-07-16       Impact factor: 4.668

Review 3.  Amide proton transfer imaging of tumors: theory, clinical applications, pitfalls, and future directions.

Authors:  Kiyohisa Kamimura; Masanori Nakajo; Tomohide Yoneyama; Koji Takumi; Yuichi Kumagae; Yoshihiko Fukukura; Takashi Yoshiura
Journal:  Jpn J Radiol       Date:  2018-10-19       Impact factor: 2.374

4.  Can amide proton transfer-weighted imaging differentiate tumor grade and predict Ki-67 proliferation status of meningioma?

Authors:  Hao Yu; Xinrui Wen; Pingping Wu; Yueqin Chen; Tianyu Zou; Xianlong Wang; Shanshan Jiang; Jinyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

5.  Myo-inositol concentration in MR spectroscopy for differentiating high grade glioma from primary central nervous system lymphoma.

Authors:  Hiroaki Nagashima; Takashi Sasayama; Kazuhiro Tanaka; Katsusuke Kyotani; Naoko Sato; Masahiro Maeyama; Masaaki Kohta; Junichi Sakata; Yusuke Yamamoto; Kohkichi Hosoda; Tomoo Itoh; Ryohei Sasaki; Eiji Kohmura
Journal:  J Neurooncol       Date:  2017-11-15       Impact factor: 4.130

6.  MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.

Authors:  Annasofia Anemone; Lorena Consolino; Dario Livio Longo
Journal:  Eur Radiol       Date:  2016-08-29       Impact factor: 5.315

7.  Prospective acceleration of parallel RF transmission-based 3D chemical exchange saturation transfer imaging with compressed sensing.

Authors:  Hye-Young Heo; Xiang Xu; Shanshan Jiang; Yansong Zhao; Jochen Keupp; Kristin J Redmond; John Laterra; Peter C M van Zijl; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2019-06-17       Impact factor: 4.668

8.  Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.

Authors:  Shanshan Jiang; Charles G Eberhart; Yi Zhang; Hye-Young Heo; Zhibo Wen; Lindsay Blair; Huamin Qin; Michael Lim; Alfredo Quinones-Hinojosa; Jon D Weingart; Peter B Barker; Martin G Pomper; John Laterra; Peter C M van Zijl; Jaishri O Blakeley; Jinyuan Zhou
Journal:  Eur J Cancer       Date:  2017-07-10       Impact factor: 9.162

Review 9.  Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum.

Authors:  Peter C M van Zijl; Wilfred W Lam; Jiadi Xu; Linda Knutsson; Greg J Stanisz
Journal:  Neuroimage       Date:  2017-04-21       Impact factor: 6.556

10.  Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.

Authors:  Kiyohisa Kamimura; Masanori Nakajo; Tomohide Yoneyama; Yoshihiko Fukukura; Hirofumi Hirano; Yuko Goto; Masashi Sasaki; Yuta Akamine; Jochen Keupp; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.